Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |